Related Experiment Video

Updated: May 28, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

C-Raf is required for the initiation of lung cancer by K-Ras(G12D)

Florian A Karreth1, Kristopher K Frese, Gina M DeNicola

  • 1Li Ka Shing Centre, Cambridge Research Institute, Cancer Research UK, Cambridge, United Kingdom.

Cancer Discovery
|November 2, 2011
PubMed

Insights

Cancer-driving K-Ras(G12D) primarily uses C-Raf, not B-Raf, for proliferation in epithelial cells and lung tumor initiation. This suggests C-Raf inhibitors may treat K-Ras-dependent cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The Ras/Raf/MEK/ERK pathway is crucial for cell growth and frequently mutated in cancers.
  • Understanding the specific roles of Raf kinases (B-Raf, C-Raf) in oncogenesis is vital for targeted cancer therapies.

Purpose of the Study:

  • To investigate the distinct roles of B-Raf and C-Raf in Ras-driven oncogenesis.
  • To determine which Raf kinase is essential for K-Ras(G12D)-induced proliferation and tumor initiation.

Main Methods:

  • Comparative analysis of B-Raf and C-Raf function in primary mesenchymal and epithelial cells.
  • Assessment of K-Ras(G12D) oncogenesis in a lung cancer mouse model, evaluating the necessity of B-Raf and C-Raf.

Main Results:

  • B-Raf and C-Raf exhibit overlapping functions in mesenchymal cells.
  • C-Raf, but not B-Raf, is required for K-Ras(G12D)-driven proliferation in epithelial cells.
  • C-Raf is essential for K-Ras(G12D) lung tumor initiation, while B-Raf is dispensable.

Conclusions:

  • K-Ras(G12D) exerts its oncogenic effects predominantly through C-Raf.
  • Selective C-Raf inhibition represents a potential therapeutic strategy for K-Ras-dependent cancers.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...